Product logins

Find logins to all Clarivate products below.


Laparoscopic Devices | Market Insights | Latin America | 2021

The COVID-19 pandemic will have a significant impact on the Latin American laparoscopic device market. Once the market stabilizes, however, it will expand moderately through 2029, driven by an expanding patient base and growth in laparoscopic procedure volumes. A set of factors such as an aging population, increased prevalence of diseases and conditions such as obesity, and also increasing demand for minimally invasive procedures also influence the market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for laparoscopic devices in Latin America across a 10-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period because a shift toward officebased procedures is driving market expansion. Procedure volume growth will also be driven by the…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…